Skip to content

Comparison of Two Surgical Techniques for Open Subpectoral Biceps Tenodesis

Comparison of Bicep Tendon Migration Between Two Techniques for Open Subpectoral Biceps Tenodesis

Status
Withdrawn
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06797128
Enrollment
0
Registered
2025-01-28
Start date
2026-01-01
Completion date
2028-12-01
Last updated
2026-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bicep Tenodesis

Brief summary

Participants who are indicated for an open biceps tenodesis procedure will be recruited to join the study. The participant will undergo the standard biceps tenodesis procedure using either one standard anchor or two mini anchors by the study staff surgeon. Both techniques are safe and considered standard of care. The participant will be randomized to either group. After the biceps are secured in the standard fashion, a sterile radiolucent bead will be applied to the tendon. The participant will undergo xray imaging in the post-anesthesia care unit to determine a baseline measurement of the location of the radiolucent bead. The participant will then undergo further xray imaging at their 2 week and 6 month-up visits.

Detailed description

Participants who are indicated for an open biceps tenodesis procedure will be recruited to join the study. The participant will undergo the standard biceps tenodesis procedure using either one standard anchor or two mini anchors by the study staff surgeon. Both techniques are safe and considered standard of care. The participant will be randomized to either group. After the biceps are secured in the standard fashion, a sterile radiolucent bead will be applied to the tendon. This will allow for measurements to be made on xray imaging in the post-operative period. The placement of the clip is the only experimental portion of the procedure. The participant will undergo xray imaging in the post-anesthesia care unit to determine a baseline measurement of the location of the radiolucent bead. The participant will then undergo further xray imaging at their 2 week and 6 month-up visits. These visits are standard visits for the participant who undergo this procedure.

Interventions

PROCEDUREOne Anchor

Participant will receive one standard anchor

PROCEDURETwo Mini Anchors

Participant will receive two mini anchors

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Participant age 18 and above who would otherwise indicated for biceps tenodesis due to biceps tendinopathy with or without associated rotator cuff pathology

Exclusion criteria

* Participant under the age of 18 will be excluded from the study as there is no indication to perform this procedure in children. * Any participant who had previous surgery or injury to their biceps or biceps tendon will be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Sterile radiolucent bead location distanceBaseline, 2-weeks, 6-monthsSterile radiolucent bead location will be measured during all 3 xrays. Comparison of these measurements will be between the two groups.

Secondary

MeasureTime frameDescription
Participant Reported Outcome VAS2-weeks, 6-monthsChange in Visual Analog Scale (VAS); minimum 0, maximum 10, higher score is a worse outcome
Participant Reported Outcome Constant2-weeks, 6-monthsConstant Score; minimum 0, maximum 100, higher score is a better outcome
Participant Reported Outcome ASES2-weeks, 6-monthsAmerican Shoulder Elbow Score (ASES); minimum 0, maximum 100, higher score is a better outcome
Participant Reported Outcome SSV2-weeks, 6-monthsSubjective Shoulder Value (SSV); minimum 0, maximum 100, higher score is a better outcome

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORMichael Freehill, MD

Stanford University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 25, 2026